197A.T JPX
TAUNS Laboratories, Inc.
1W: -3.6%
1M: +0.6%
3M: +7.8%
YTD: -9.1%
1Y: -6.6%
¥511.00 ($3.24)
+2.00 (+0.39%)
Weekly Expected Move ±1.9%
¥490
¥499
¥509
¥519
¥528
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$2.8B
-141.4% ▼
Capital Expenditures
$3.8B
+19.1% ▲
4Y CAGR: +13.3%
Free Cash Flow
-$6.6B
-409.4% ▼
Dividends Paid
$3.7B
-34.7% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5.7B
-3503.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $4.5B | $3.0B | $5.8B | $6.3B | $5.5B |
| Depreciation & Amort. | $567M | $640M | $676M | $715M | $1.1B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$231M | -$3.3B | $1.7B | $823M | -$6.5B |
| Other Non-Cash Items | $5.9B | -$3.6B | $1.8B | -$1.0B | -$2.9B |
| Operating Cash Flow | $10.7B | -$3.2B | $9.9B | $6.8B | -$2.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$2.3B | -$1.2B | -$3.8B | -$5.1B | -$4.0B |
| Acquisitions (Net) | $55K | -$299M | -$150M | $5M | $4M |
| Investment Purchases | -$381M | -$151M | -$151M | -$4.1B | -$1.9B |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $1M | -$1K | -$56M | $0 | -$215M |
| Investing Cash Flow | -$2.7B | -$1.6B | -$4.1B | -$9.3B | -$6.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.9B | $1.6B | $3.0B | $4.9B | $6.8B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1.8B | -$1.9B | -$600M | -$2.8B | -$3.7B |
| Other Financing | $0 | $0 | -$16M | -$1K | -$1K |
| Financing Cash Flow | -$3.7B | -$330M | $2.4B | $2.3B | $3.3B |
| Net Change in Cash | $6.3B | -$5.1B | $8.2B | -$158M | -$5.7B |
| Cash End of Period | $6.3B | $1.2B | $9.4B | $9.3B | $3.6B |
| Free Cash Flow | $8.4B | -$4.3B | $6.0B | $2.1B | -$6.6B |